Director Daniel W. Geballe filed a statement of changes in beneficial ownership with the SEC on November 6, 2026, reporting the acquisition of 137 dividend equivalent rights linked to Levi Strauss & Co Class A Common Stock on November 4, 2026.
AMTD Group Inc., AMTD IDEA Group, and The Generation Essentials Group filed a Schedule 13D Amendment No. 3 with the SEC disclosing their beneficial ownership positions in AMTD Digital Inc. following a share issuance event on November 2, 2026.
Netclass Technology Inc filed a Form 6-K with the SEC on November 6, 2026, disclosing the closing of a registered direct offering that raised approximately $1.2 million in gross proceeds through the sale of Class A ordinary shares, pre-funded warrants, and allocation rights.
Director Jill Beraud filed a Form 4 with the SEC on November 6, 2026, disclosing transactions in Levi Strauss & Co. (NYSE:LEVI) Class A and Class B Common Stock dated November 4, 2026.
Rallybio Corporation filed a current report on November 6, 2026, disclosing that the planned closing of its merger with Avenzo Therapeutics, Inc. has been postponed because certain conditions related to the listing of the company's shares following the closing have not been satisfied.
Pono Capital Four, Inc. filed a current report on Form 8-K on November 6, 2026, disclosing a First Amendment to its Merger Agreement with Blackstar Orbital Technologies Corporation, executed on November 5, 2026, that reduces the Base Purchase Price and extends the closing deadline.
Director Troy Alstead filed a Form 4 with the SEC on November 6, 2026, disclosing changes in beneficial ownership of Levi Strauss & Co (NYSE:LEVI) Class A and Class B Common Stock resulting from transactions dated November 4, 2026.
Saba Capital Management, L.P. filed a Form 4 on November 6, 2026, disclosing a purchase of common stock in BNY Mellon Strategic Municipal Bond Fund, Inc. on November 5, 2026.
Rallybio Corporation filed a current report on November 6, 2026, disclosing that the planned closing of its merger with Avenzo Therapeutics, Inc. has been postponed because certain listing conditions required for completion of the transaction have not been satisfied.
Craig Packer, Co-President and Director of Blue Owl Capital Inc., reported the acquisition of 730,542 Class C Shares and a corresponding number of Blue Owl Operating Group Units on November 5, 2026, in a statement of changes in beneficial ownership filed with the SEC …